BEAT CKD-Logo-Final

BEAT-CKD Chief Investigator publications

January 2016

1. Baan CC, Bromberg JS, Chapman JR, Geissler EK, Pomfret EA,   Tullius SG. Transplantation Reaches 100th Volume. Transplantation. 2016;100(1):1. Jan. DOI: 10.1097/01.TP.0000475956.36941.e6

2. Chan S, Fahim MA, Macdonald GA, Johnson DW. Treatment of hepatitis B in patients with chronic kidney disease. In: Hepatitis B treatment, Avid Science, Berlin, Germany, 2016.

3. Cho Y, Johnson DW, Vesey DA, Hawley CM, Pascoe EM, Clarke M, Topley, N. Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction. Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis. 2016;36(1):16-25. Jan-Feb. DOI: 10.3747/pdi.2013.002743.

4. Howell M, Wong G, Rose J, Tong A, Craig JC, Howard K. Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: a pilot best-worst scaling survey. BMJ Open. 2016;6(1):e008163. Jan 27. DOI: 10.1136/bmjopen-2015-0081634.

5. Mahmood U, Cho Y, Johnson DW. Peritoneal dialysis solutions. In: Ekart R (ed.), Peritoneal dialysis, InTech, Rijeka, Croatia, 2016.

6. Ma MK, Lim WH, Craig JC, Russ GR, Chapman JR, Wong G. Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors. Clinical Journal of the American Society of Nephrology. 2016;11(1):128-36. Jan 7. DOI: 10.2215/CJN.037604155.

7. Mudge DW, Boudville N, Brown F, Clayton P, Duddington M, Holt S, Johnson DW, Jose M, Sawiers W, Sud K, Voss D, Walker R. Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action. Nephrology. 2016. Jan 25. DOI: 10.1111/nep.12731.

8. Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe EM, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP. Centre-specific factors associated with peritonitis risk-A multi-center registry analysis. Peritoneal Dialysis International. 2016. Jan 13. DOI:10.3747/pdi.2015.001467.

9. Nataatmadja M, Cho Y, Fahim M, Johnson DW. Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease: An Update. Reviews on Recent Clinical Trials. 2016;11(1):12-32. Jan.8.

10. Ralph AF, Alyami A, Allen RD, Howard K, Craig JC, Chadban SJ, Irving M, Tong A. Attitudes and beliefs about deceased organ donation in the Arabic-speaking community in Australia: a focus group study. BMJ open. 2016;6(1):e010138. Jan 21. DOI:10.1136/bmjopen-2015-0101389.

11. See E, Hawley CM, Agar J, Johnson DW. Fluid convection, generation and reinfusion in haemodiafiltraton. In: Karkar A (ed.), Advances in Hemodiafiltration, InTech, Rijeka, Croatia, 2016.

12. Taylor MJ, Hanson CS, Casey JR, Craig JC, Harris D, Tong A. “You know your own fistula, it becomes a part of you”-Patient perspectives on vascular access: A semistructured interview study.Hemodialysis International. 2016;20(1):5-14. Jan. DOI: 10.1111/hdi.12340

 

February 2016

1. Brown DP, Chapman JR. Care of Transplant Recipients in Primary Practice. Transplantation.   2016;100(3):474-6. Feb 24. DOI: 10.1097/TP.0000000000001139

2. Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Tong A. Nephrologists’ Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation. Transplantation. 2016;100(4):943-53. Feb 10. DOI: 10.1097/tp.0000000000000921

3. Joseph PD, Caldwell PH, Tong A, Hanson CS, Craig JC. Stakeholder Views of Clinical Trials in Low- and Middle-Income Countries: A Systematic Review. Pediatrics. 2016;137(2):1-19. Feb. DOI:10.1542/peds.2015-2800

4. Krishnasamy R, Hawley CM, Stanton T, Howden EJ, Beetham KS, Strand H, Leano R, Haluska BA, Coombes JS, Isbel NM. Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction. Nephrology 2016 (DOI: 10.1111/nep.12557).

5. Lim WH, McDonald SP, Coates PT, Chapman JR, Russ GR, Wong G. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. Kidney International. 2016;89(3):659-65. Feb 18. DOI: 10.1016/j.kint.2015.11.016

6. O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, Parker D, Whiteley W, Strippoli GF, Palmer SC, Craig JC, Webster AC. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016 Feb 23. DOI: 10.1053/j.ajkd.2015.12.028

7. Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GFM. Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrology Dialysis Transplantation 2016; 0:1-7

8. Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. Clinical Journal of the American Society of Nephrology. 2016;11(2):223-31. Feb 5. DOI: 10.2215/CJN.0524051

9. Tong A, Tunnicliffe DJ, Lopez-Vargas P, Mallett A, Patel C, Savige J, Campbell K, Patel M, Tchan MC, Alexander SI, Lee V, Craig JC, Fassett R, Rangan GK. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology 2016;21(2):122-32. Feb. DOI: 10.1111/nep.12579

10. Zhang L, Hawley CM, Johnson DW. Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrology, Dialysis, Transplantation. 2016;31(2):214-22. Feb 26. DOI: 10.1093/ndt/gfu403

 

March 2016

1. Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology. 2016 (DOI10.1007/s10157-016-1255-y)

2. Brown DP, Chapman JR. Care of Transplant Recipients in Primary Practice. Transplantation. 2016;100(3):474-6. (DOI 10.1097/tp.0000000000001139)

3. Chapman JR, Delmonico FL. Buyer beware transplantation. Kidney Int. 2016;89(5):983-5. (DOI 10.1016/j.kint.2016.01.021)

4. Cho Y, Buchel J, Steppan S, Passlick-Deetjen J, Hawley CM, Dimeski G, Clarke M, Johnson DW. Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions. Peritoneal Dialysis International 2016; 36(2): 146-153. (DOI: 10.3747/pdi.2014.00291)

5. Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C. Indoxyl sulphate and kidney disease: Causes, consequences and interventions. Nephrology 2016;21(3):170-7. (DOI10.1111/nep.12580)

6. Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, Budde K, Tong A. Motivations, Challenges, and Attitudes to Self-management in Kidney Transplant Recipients: A Systematic Review of Qualitative Studies. American Journal of Kidney Diseases 2016;67(3):461-78. (DOI 10.1053/j.ajkd.2015.07.030)

7. Lim WH, McDonald SP, Coates PT, Chapman JR, Russ GR, Wong G. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. Kidney Int. 2016;89(3):659-65. (DOI 10.1016/j.kint.2015.11.016)

8. Lopez-Vargas PA, Tong A, Howell M, Craig JC. Educational Interventions for Patients With CKD: A Systematic Review. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.01.022)

9. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, Schick-Makaroff K,Wheeler DC,van Biesen W, Winkelmayer WC, Johnson DW, Howard K, Evangelidis N, Tong A. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.02.037)

10. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi SL, Ong ML, Irish AB. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology 2016;21(3):217-28. (DOI 10.1111/nep.12573)

 

April 2016

1. Badve SV, Palmer SC, Strippoli GF, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath S S, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.03.418)

2. Caldwell PH, Sureshkumar P, Kerr MI, Hamilton S, Teixeira-Pinto A, Macaskill P, Craig JC. A randomised controlled trial of a code-word enuresis alarm. Archives of Disease in Childhood. 2016;101(4):326-31. (DOI 10.1136/archdischild-2015-308564)

3. Campbell DJ, Brown FG, Craig JC, Gallagher MP, Johnson DW, Kirkland GS, Kumar SK, Lim WH, Ranganathan D, Saweirs W, Sud K, Toussaint ND, Walker RG, Williams LA, Yehia M, Mudge DW. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrology, Dialysis, Transplantation. 2016;31(4):619-27. (DOI 10.1093/ndt/gfv115)

4. Chapman JR, Delmonico FL. Buyer beware transplantation. Kidney Int. 2016;89(5):983-5. (DOI 10.1016/j.kint.2016.01.021)

5. Clayton PA, Saunders JR, McDonald SP, Allen RD, Pilmore H, Saunder A, Boudville N, Chadban SJ. Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012. Transplantation 2016;100(6):1278-83. (DOI10.1097/tp.0000000000000877)

6. Fahim MA, Hayen AD, Horvath AR, Dimeski G, Coburn A, Tan KS, Johnson DW, Craig JC, Campbell SB, Hawley CM. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clinical chemistry and laboratory medicine. 2016;54(5):e149-50. (DOI 10.1515/cclm-2015-0998)

7. Gobe GC, Ng KL, Small DM, Vesey DA, Johnson DW, Samaratunga H, Oliver K, Wood S, Barclay JL, Rajandram R, Li L, Morais C. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways. Biochemical and Biophysical Research Communications. 2016;473(1):47-53. (DOI 10.1016/j.bbrc.2016.03.048)

8. Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P. Association between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Nephrology 2016. (DOI 10.1111/nep.12815)

9. Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Tong A. Nephrologists’ Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation. Transplantation. 2016;100(4):943-53. (DOI 10.1097/tp.0000000000000921)

10. Hoy WE, Mott SA, McDonald SP. An expanded nationwide view of chronic kidney disease in Aboriginal Australians. Nephrology 2016. (DOI 10.1111/nep.12798)

11. Krishnan AR, Wong G, Chapman JR, Coates PT, Russ GR, Pleass H, Russell C, He B, Lim WH. Prolonged Ischemic Time, Delayed Graft Function, Graft and Patient Outcomes in Live-Donor Kidney Transplant Recipients. American Journal of Transplantation 2016. (DOI 10.1111/ajt.13817)

12. Lan PG, Clayton PA, Johnson DW, McDonald SP, Borlace M, Sud K, Badve SV, Boudville N. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure. Peritoneal Dialysis International 2016. (DOI 10.3747/pdi.2015.00218)

13. Lim WH, Chapman JR, Coates PT, Lewis JR, Russ GR, Watson N, Holdsworth R, Wong G. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology 2016;11(5):875-83. (DOI 10.2215/cjn.11641115)

14. Lo P, Sharma A, Craig JC, Wyburn K, Lim W, Chapman JR, Palmer SC, Strippoli GF, Wong G. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis. Transplantation 2016;100(4):933-42. (DOI 10.1097/tp.0000000000000933)

15. Marshall MR, Polkinghorne KR, Kerr PG, Hawley CM, Agar JW, McDonald SP. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations. American Journal of Kidney Diseases 2016;67(4):617-28. (DOI 10.1053/j.ajkd.2015.09.025)

16. Nadeau-Fredette AC, Johnson DW. Opponent’s comments. Nephrology, Dialysis, Transplantation. 2016;31(4):524. (DOI 10.1093/ndt/gfw031a)

17. Nadeau-Fredette AC, Johnson DW. Con: Buttonhole cannulation of arteriovenous fistulae. Nephrology, Dialysis, Transplantation 2016;31(4):525-8.(DOI 10.1093/ndt/gfw030)

18. Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Isbel NM, Krum H, Pascoe EM, Perkovic V, Scaria A, Tonkin AM, Vergara LA, Hawley CM. The beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial. American Journal of Kidney Diseases 2016;67(6):902-11. (DOI 10.1053/j.ajkd.2015.10.029)

19. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB. Updates on Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology 2016. (DOI 10.1111/nep.12823)

20. Young C, Tong A, Sherriff S, Kalucy D, Fernando P, Muthayya S, Craig JC. Building better research partnerships by understanding how Aboriginal health communities perceive and use data: a semistructured interview study. BMJ Open. 2016;6(4):e010792. (DOI 10.1136/bmjopen-2015-010792)

21. Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney Int. 2016;89(6):1337-45. (DOI 10.1016/j.kint.2016.02.014)

22. Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh C A, Polkinghorne KR, Johnson DW. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study. Nephrology 2016;21(5):387-96. (DOI 10.1111/nep.12629)

 

May 2016

1. Boonprasert K, Vesey DA, Gobe GC, Moore MR, Ruenweerayut R, Johnson DW, Na-Bangchang K, Satarug S. The stress response of human proximal tubules cells to cadmium involves up-regulation of haemoxygenase-1 and metallothionein but not cytochrome P450 enzymes. Toxicology Letters 2016; 249: 5-14.

2. Howard K, Jan S, Rose JM, Wong G, Craig JC, Irving M, Tong A, Chadban S, Allen RD, Cass A. Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment. Transplantation 2016;100(5):1136-48 (DOI: 10.1097/TP.0000000000000940)

3. Howell M, Wong G, Turner RM, Tan HT, Tong A, Craig JC, Howard K. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016;67(5):762-74 (DOI: 10.1053/j.ajkd.2015.11.006)

4. Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation 2016 (DOI: 10.1093 /ndt/gfw075)

5. Mahady SE, Gale J, Macaskill P, Craig JC, George J. Prevalence of elevated alanine transaminase (ALT) in Australia and its relationship to metabolic risk factors: a cross sectional study of 9,447 people. Journal of Gastroenterology and Hepatology 2016 (DOI: 10.1111 /jgh.13434)

6. Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, Tong A. Patients’ Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Journal of Gastroenterology and Hepatology 2016;43(7):1363-75 (DOI: 10.1111/ jgh.13434 10.3899/jrheum.151309)

7. Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. The Cochrane Database of Systematic Reviews 2016(5):Cd004541 (DOI: 10.1002/14651858.CD004541.pub3)

8. Perl J, Davies SJ, Lambie M, Pisoni RL, McCullough K, Johnson DW, Sloand JA, Prichard S, Kawanishi H, Tentori F, Robinson BM. The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis. Peritoneal Dialysis International 2016;36(3):297-307 (DOI: 10.3747/pdi.2014.00288)

9. Tong A, Craig JC. Tuning into Qualitative Research-A Channel for the Patient Voice. Clinical Journal of the American Society of Nephrology 2016 (DOI: 10.2215/cjn.05110516)

10. Torres VE, Higashihara E, Devuyst O, Chapman AB, Gansevoort RT, Grantham JJ, Perrone RD, Ouyang J, Blais JD, Czerwiec FS for the TEMPO 3:4 Trial Investigators. Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial. Clinical Journal of the American Society of Nephrology 2016; 11(5): 803-11.

 

June 2016

1. Cai TY, Magnussen C, Haluska B, Johnson DW, Mottram PM, Isbel N, Celermajer DS, Marwick TH, Skilton MR. Carotid extra-medial thickness does not predict adverse cardiovascular outcomes in high-risk adults. Diabetes Metabolism 2016; 42(3): 200-203. (DOI: 10.1016/j.diabet.2015.12.001)

2. Francis A, Didsbury M, Lim WH, Kim S, White S, Craig JC, Wong G. The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatric Nephrology 2016; 31(6): 1011-1019. (DOI: 10.1007/s00467-015-3279-z)

3. Hanson CS, Chapman JR, Craig JC, Harris DC, Kairaitis LK, Nicdao M, Mikaheal M, Tong A. Patient experiences of training and transition to home haemodialysis: A mixed-methods study. Nephrology 2016; (DOI: 10.1111/nep.12827)

4. Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC. Beginning the trajectory to ESKD in adult life: Albuminuria in Australian aboriginal children and adolescents. Pediatric Nephrology 2016; (DOI: 10.1007/s00467-016-3429-y)

5. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Peritoneal Dialysis International 2016. (DOI: 10.3747/pdi.2016.00078)

6. Lopez-Vargas P A, Tong A, Howell M, Phoon RK, Chadban SJ, Shen Y, Craig JC. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease – a mixed-methods study. Nephrology 2016 (DOI: 10.1111/nep.12829)

7. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. Journal of the American Society of Nephrology 2016. (DOI: 10.1681/asn.2016010112)

8. Mudge DW, Webster AC, Johnson DW . Pro: Meta-analysis: The case for. Nephrology Dialysis and Transplant 2016; 31(6): 875-880. (DOI: 10.1093/ndt/gfw091)

9. Tong A, Budde K, Gill J, Josephson MA, Marson L, Pruett TL, Reese PP, Rosenbloom D, Rostaing L, Warrens AN, Wong G, Craig JC, Crowe S, Harris T, Hemmelgarn B, Manns B, Tugwell P, Van Biesen W, Wheeler DC, Winkelmayer WC, Evangelidis N, Sautenet B, Howell M, Chapman JR. Standardized outcomes in nephrology-transplantation: A global initiative to develop a core outcome set for trials in kidney transplantation. Transplant Direct 2016; 2(6): e79. (DOI: 10.1097/txd.0000000000000593)

10. Tong A, Palmer S, Craig JC, Strippoli GF. A guide to reading and using systematic reviews of qualitative research. Nephrology Dialysis Transplantation 2016; 31(6): 897-903. (DOI: 10.1093/ndt/gfu354)

11. Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW,O’Neill SG, Ralph AF, Craig JC, Tong A. Lupus means sacrifices: Perspectives of adolescents and young adults with systemic lupus erythematosus. Arthritis Care Research 2016; 68(6): 828-837. (DOI: 10.1002/acr.22749)

12. Young V, Balaam S, Orazio L, Bates A, Badve SV, Johnson DW, Campbell KL. Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis. Journal of Renal Care,2016; 42(2): 123-131. (DOI: 10.1111/jorc.12156)

 

July 2016

1. Badve SV, Pascoe E M, Burke M, Clayton PA, Campbell SB, Hawley CM,Lim WH, McDonald SP, Wong G, Johnson DW. Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients. Clinical Journal of the American Society of Nephrology 2016. (DOI: 10.2215/cjn.00190116)

2. Briskey D, Tucker PS, Johnson DW, Coombes JS. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Nitric Oxide 2016; 57: 64-70. (DOI: 10.1016/j.niox.2016.05.002)

3. Davis E, Campbell K, Gobe G, Hawley C, Isbel N, Johnson DW. Association of anthropometric measures with kidney disease progression and mortality: A retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. BMC Nephrology 2016; 17(1): 74. (DOI: 10.1186/s12882-016-0290-y)

4. Kim S, Macaskill P, Baur LA, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig, JC. The differential effect of socio-economic status, birth weight and gender on body mass index in Australian aboriginal children. International Journal of Obesity 2016; 40(7): 1089-1095. (DOI: 10.1038/ijo.2016.71)

5. Lim WH, McDonald SP, Russ GR, Chapman JR, Ma MK, Pleass H, Jaques B, Wong G. Association between delayed graft function and graft loss in donation after cardiac death kidney transplants – a paired kidney registry analysis. Transplantation 2016. (DOI: 10.1097/tp.0000000000001323)

6. Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, George J. Elevated liver enzymes and mortality in older individuals: A prospective cohort study. Journal of Clinical Gastroenterology 2016. (DOI: 10.1097/mcg.0000000000000622)

7. Miller HM, Tong A, Tunnicliffe DJ, Campbell D, Pinter J, Commons RJ, Athan E, Craig JC, Gilroy N, Green J, Henderson B, Howell M, Stuart RL, van Eps C, Wong MG, de Zoysa J, Jardine MJ. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International 2016; 21(2), 213-223(DOI: 10.1111/hdi.12457)

8. Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Phosphate-binding agents in adults with CKD: A network meta-analysis of randomized trials. American Journal of Kidney Diseases 2016. (DOI: 10.1053/j.ajkd.2016.05.015)

9. Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De berardis G, Ruospo M, Natale P. Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruquw L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: A meta-analysis. Journal of the American Medical Association 2016; 316(3): 313-324. (DOI: 10.1001/jama.2016.9400)

10. Shen K, Johnson DW, Gobe GC. The role of cyclic gmp and its signaling pathways in kidney disease. American Journal of Physiology and Renal Physiology 2016. (DOI: 10.1152/ajprenal.00042.2016)

11. Wong G, Teixeira-Pinto A, Chapman JR, Craig JC, Pleass H, McDonald S, Lim WH. The impact of total ischaemic time, donor age and the pathway of donor death on graft outcomes after deceased donor kidney transplantation. Transplantation 2016. (DOI: 10.1097/tp.0000000000001351)

12. Wright D, Gordon R, Carr D, Craig JC, Banks E, Muthayya S, Wutzke S, Eades SJ, Redman S. The study of environment on aboriginal resilience and child health (search): A long-term platform for closing the gap. Public Health Research Practice 2016; 26(3). (DOI: 10.17061/phrp2631635)

 

August 2016

1. Chapman JR, Wong G. Cancer in patients with inherited ciliopathies: Polycystic kidney disease. Lancet Oncology 2016. (DOI: 10.1016/s1470-2045(16)30307-2)

2. Hodson EM, Craig JC. How randomised trials have improved the care of children with kidney disease. Pediatric Nephrology 2016. (DOI: 10.1007/s00467-016-3455-9)

3. Johnson DW. Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes. Evidence Based Medicine 2016 (DOI: 10.1136/ebmed-2016-110418)

4. Lim WH, McDonald SP, Kennedy S E, Larkins N, Wong G. Association between slow and delayed graft function with graft outcomes in paediatric and adolescent deceased donor kidney transplant recipients. Transplantation 2016. (DOI: 10.1097/tp.0000000000001464)

5. Masson P, Kotwal S, Kelly PJ, Craig JC, Lindley RI, Gallagher M.Cass A, Webster AC. Risk factors for stroke in people with end-stage kidney disease: A cohort study. Cerebrovascular Diseases 2016; 42(5-6): 428-438. (DOI: 10.1159/000445067)

6. Nataatmadja M, Cho Y, Lloyd J, Johnson DW. Aminoglycoside use in patients with chronic kidney disease. In: Kruger E (ed.), Aminoglycosides: Pharmacology, Clinical Uses and Health Effects, Nova Science, New York, 2016.

7. Nankivell BJ, P’Ng CH, O’Connell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: Comparison of cyclosporine and tacrolimus eras. Transplantation 2016; 100(8): 1723-1731. (DOI: 10.1097/tp.0000000000001243)

8. Norvell DC, Dettori JR, Chapman JR. Enhancing clinical study retention rates to avoid follow-up bias: How do we keep our study participants from “the land of the lost”? Global Spine Journal 2016; 6(5): 519-521. (DOI: 10.1055/s-0036-1584928)

9. Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P,Crowe S, Van Biesen W, Winkelmayer WC, O’Donoghue D, Tam-Tham H, Shen JI, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC. Establishing core outcome domains in hemodialysis: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. American Journal of Kidney Disease 2016. (DOI: 10.1053/j.ajkd.2016.05.022)

10. Tong A, Samuel S, Zappitelli M, Dart A, Furth S, Eddy A,Groothoff J, Webb NJ, Yap HK, Bockenhauer D, Sinha A, Alexander SI, Goldstein SL, Gipson DS, Hanson CS, Evangelidis N, Crowe S, Harris T, Hemmelgarn BR, Manns B, Gill J, Tugwell P, VanBiesen W, Wheeler DC, Winkelmayer WC, Craig JC. Standardised outcomes in nephrology-children and adolescents (SONG-kids): A protocol for establishing a core outcome set for children with chronic kidney disease. Trials 2016; 17: 401. (DOI: 10.1186/s13063-016-1528-5)

 

September 2016

1. Adams RJ, Appleton S L, Vakulin A, Hanly PJ, McDonald SP, Martin SA, Lang C J, Taylor AW, McEvoy RD, Antic NA, Catcheside PG, Vincent AD, Wittert G A. Association of kidney disease with obstructive sleep apnea in a population study of men. Sleep 2016; Sept 9 pii: sp-00240-16

2. Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Journal of Immunology 2016; 31(9), 1425-1436. (DOI: 10.4049/jimmunol.1600990 10.1093/ndt/gfv269)

3.  Campbell DJ, Craig JC, Mudge DW, Brown FG, Wong G, Tong A. Patients’ perspectives on the prevention and treatment of peritonitis in peritoneal dialysis: A semi-structured interview study. Peritoneal Dialysis International 2016; Sept 28 (DOI: 10.3747/pdi.2016.00075)\

4. Chando S, Young C, Craig JC, Gunasekera H, Tong A. Parental views on otitis media: Systematic review of qualitative studies. European Journal of Pediatrics 2016; 175(10): 1295-1305. (DOI: 10.1007/s00431-016-2779-6)

5. Chong L, Jamieson N J, Gill D, Singh-Grewal D, Craig JC, Ju A Hanson CS, Tong A. Children’s experiences of epilepsy: A systematic review of qualitative studies. Pediatrics 2016; 138(3). (DOI: 10.1542/peds.2016-0658)

6. Krishnan  AR, Wong G, Chapman JR, Coates PT, Russ GR, Pleass H, Russell C, He B, Lim, W. H. Prolonged ischemic time, delayed graft function, and graft and patient outcomes in live donor kidney transplant recipients. Am J Transplant 2016; 16(9): 2714-2723. (DOI: 10.1111/ajt.13817)

7. Liuzzi A R, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC, Roberts GW, Donovan KL, Colmont CS, Toleman MA, Bowen T, Johnson DW, Topley N, Moser B, Fraser DJ, Eberl M. Unconventional human t cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. Journal of Immunology 2016; 197(6): 2195-2207. (DOI: 10.4049/jimmunol.1600990)

8. Lopez-Vargas PA, Tong A, Howell M, Craig JC. (2016). Educational interventions for patients with ckd: A systematic review. Am J Kidney Dis, 68(3), 353-370. doi: 10.1053/j.ajkd.2016.01.022

9. O’Connell P J, Zhang W, Menon M C, Yi Z, Schroppel B, Gallon L, Luan Y, Rosales I A, Ge Y, Losic B, Xi C, Woytovich C, Keung K L, Wei C, Greene I, Overbey J, Bagiella E, Najafian N, Samaniego M, Djamali A, Alexander SI, Nankivell B J, Chapman JR, Smith RN, Colvin R, Murphy B. Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: A multicentre, prospective study. Lancet 2016; 388(10048): 983-993. (DOI: 10.1016/s0140-6736(16)30826-1)

10. Pinter J, Hanson CS, Craig JC, Chapman JR, Budde K, Halleck F, Tong A. ‘I feel stronger and younger all the time’-perspectives of elderly kidney transplant recipients: Thematic synthesis of qualitative research. Nephrology Dialysis Transplantation 2016; 31(9): 1531-1540. (DOI: 10.1093/ndt/gfv463)

11. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, Schick-Makaroff K, Wheeler DC, van Biesen W, Winkelmayer, WC, Johnson DW, Howard K, Evangelidis N, Tong A. Patient and caregiver priorities for outcomes in hemodialysis: An international nominal group technique study. Am J Kidney Disease 2016; 68(3):444-454. (DOI: 10.1053/j.ajkd.2016.02.037)

 

October 2016

1. Badve SV, Palmer SC, Strippoli GF, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW. The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: A systematic review and meta-analysis. American Journal of Kidney Disease 2016;68(4): 554-563. (DOI: 10.1007/s00431-016-2779-610.1053/j.ajkd.2016.03.418)

2. Barraclough KA, Grace BS, Lawton P, McDonald SP. Residential location and kidney transplant outcomes in indigenous compared with nonindigenous Australians. Transplantation 2016; 100(10): 2168-2176. (DOI: 10.1097/tp.0000000000001007)

3. Chan S, Campbell SB, Clayton PA, Mudge DW, Cho Y, Hawley CM, Johnson DW, Francis RS. Temporal changes in deceased kidney donor characteristics in Australia. Transplantation Direct 2016; 2(11): e112. (DOI: 10.1097/txd.0000000000000624)

4. Chapman JR, Wong G. Cancer in patients with inherited ciliopathies: Polycystic kidney disease. Lancet Oncology 2016; 17(10): 1343-1345. (DOI: 10.1016/s1470-2045(16)30307-2)

5. Hodson EM, Wong SC, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Systematic Reviews 2016; 10, Cd003594. (DOI: 10.1002/14651858.CD003594.pub5)

6. Johnson DW. Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes. Evid Based Med 2016; 21(5): 178. (DOI: 10.1136/ebmed-2016-110418)

7. Joseph PD, Craig JC, Tong A, Caldwell PH. Researchers’, regulators’, and sponsors’ views on pediatric clinical trials: A multinational study. Pediatrics 2016; 138(4). (DOI: 10.1542/peds.2016-1171)

8. Kasza J, Wolfe R, McDonald SP, Marshall MR, Polkinghorne KR. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study. Nephrology 2016; 21(10): 878-886. (DOI: 10.1111/nep.12688)

9. Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC. Obesity and hypertension in australian young people: Results from the Australian health survey 2011 to 2012. Internal Medicine Journal 2016;  (DOI: 10.1111/imj.13298)

10. Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GF. Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrology Dialysis Transplantation. 2016; 31(10): 1647-1653. (DOI: 10.1053/j.ajkd.2016.03.41810.1093/ndt/gfv413)

11. Shen K, Johnson DW, Gobe GC. The role of cgmp and its signaling pathways in kidney disease. American Journal of Physiology Renal Physiology. 2016; 311(4): F671-f681. (DOI:10.1152/ajprenal.00042.2016)

12. Sherriff S, Kalucy D, Fernando P, Hanson CS, Craig JC, Tong A. In their own words: The value of qualitative research to improve the care of children with chronic kidney disease. Journal of Paediatrics and Child Health. 2016. (DOI: 10.1111/jpc.13374)

13. Young C, Tong A, Gunasekera H, Sheriff S, Kalucy D, Fernando P, Craig JC. Health professional and community perspectives on reducing barriers to accessing specialist health care in metropolitan aboriginal communities: A semi-structured interview study. Journal of Paediatrics and Child Health. 2016; (DOI: 10.1111/jpc.13374)

 

November 2016

1. Chan S, Campbell SB, Clayton PA, Mudge DW, Cho Y, Hawley CM, Johnson DW, Francis RS. Temporal changes in deceased kidney donor characteristics in Australia. Transplant Direct 2016; 2(11): e112.  (DOI: 10.1097/txd.0000000000000624)

2. Chapman JR. Progress in transplantation: Will it be achieved in big steps or by marginal gains? American Journal of Kidney Disease 2016 (DOI: 10.1053/j.ajkd.2016.08.024)

3. Duffy DL, McDonald SP, Hayhurst B, Panagiotopoulos S, Smith TJ, Wang XL, Wilcken DE, Duarte NL, Mathews J, Hoy WE. Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ace and tp53. BMC Nephrology 2016; 17(1): 183. (DOI: 10.1186/s12882-016-0396-2)

4. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. Journal of the American Society of Nephrology 2016; 27(11): 3238-3252. (DOI: 10.1681/asn.2016010112)

5. Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Phosphate-binding agents in adults with ckd: A network meta-analysis of randomized trials. American Journal of Kidney Disease. 2016; 68(5): 691-702. (DOI: 10.1053/j.ajkd.2016.05.015)

6. Ralph AF, Butow P, Hanson CS, Chadban SJ, Chapman JR, Craig JC,  Kanellis J, Luxton G, Tong A. Donor and recipient views on their relationship in living kidney donation: Thematic synthesis of qualitative studies. American Journal of Kidney Disease 2016; (DOI: 10.1053/j.ajkd.2016.09.017)

7. Wong G, Chakera A, Chapman JR, Chadban SC, Pilmore H, Craig JC, Lim WH. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system? Transplant Infectious Disease. 2016 (DOI: 10.1111/tid.12631)

 

December 2016

1. Chapman JR. Message from the editor. Transplantation. 2016 (DOI: 10.1097/tp.0000000000001594)

2. Didsbury MS, Kim S, Medway MM, Tong A, McTaggart SJ, Walker AM, White S, Mackie FE, Kara T, Craig JC, Wong G. Socio-economic status and quality of life in children with chronic disease: A systematic review. J Paediatr Child Health 2016; 52(12): 1062-1069. (DOI: 10.1111/jpc.13407)

3. Do Nguyen HT, Wong G, Chapman JR, McDonald SP, Coates PT, Watson N, Russ GR, D’Orsogna L, Lim WH. The association between broad antigen HLA mismatches, Eplet HLA mismatches and acute rejection after kidney transplantation. Transplant Direct 2016; 2(12): e120. (DOI: 10.1097/txd.0000000000000632)

4. Hodson, EM, Craig JC. How randomised trials have improved the care of children with kidney disease. Pediatr Nephrol 2016; 31(12): 2191-2200.  (DOI: 10.1007/s00467-016-3455-9)

5. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naiker S,  Pecoits-Filho R, Yu  XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 2016. (DOI: 10.1038/nrneph.2016.181)

6. Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW. Predictors of residual renal function decline in peritoneal dialysis patients: The balanz trial. Peritoneal Dialalysis International 2016. (DOI: 10.3747/pdi.2016.00206)

7. Nataatmadja M, Cho Y, Johnson DW. Evidence for biocompatible peritoneal dialysis solutions. Contrib Nephrol 2016, 189, 91-101. (DOI: 10.1159/000450690)

8. See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW. Early and late patient outcomes in urgent-start peritoneal dialysis. Perit Dial Int 2016. (DOI: 10.3747/pdi.2016.00158)

9. Wai SN, Kelly JT, Johnson DW, Campbell KL. Dietary patterns and clinical outcomes in chronic kidney disease: The CKD.Qld nutrition study. Journal of Renal Nutrition. 2016 (DOI: 10.1053/j.jrn.2016.10.005)

10. Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX. Patterns and predictors of screening for breast and cervical cancer in women with ckd. Clin J Am Soc Nephrol 2017; 12(1), 95-104. (DOI: 10.2215/cjn.05990616)

11. Xu R, Yang Z, Qu Z, Wang H, Tian X, Johnson DW, Dong J. Intraperitoneal vancomycin plus either oral moxifloxacin or intraperitoneal ceftazidime for the treatment of peritoneal dialysis-related peritonitis: A randomized controlled pilot study. Am J Kidney Dis 2016. (DOI: 10.1053/j.ajkd.2016.11.008)

12. Young C, Gunasekera H, Kong K, Purcell A, Muthayya S, Vincent F, Vincent F, Wright D, Gordon R, Bell J, Gillor G, Booker J, Fernando P, Kalucy D, Sherriff S, Tong A, Parter C, Bailey S, Redman S, Banks E, Craig JC. A case study of enhanced clinical care enabled by aboriginal health research: The hearing, ear health and language services (heals) project. Australian New Zealand Journal of Public Health 2016; 40(6): 523-528.  (DOI: 10.1111/1753-6405.12586)

13. Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW. Representativeness of honeypot trial participants to Australasian PD patients. Peritoneal Dialysis International. 2016. (DOI: 10.3747/pdi.2016.00065)

 

January 2017

1. Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Howard K, Johnson DW, Jose M, Lee A, Maley M, Maley J, Pascoe EM, Steiner GZ, Tomlins M, Voss D, Chow J. Teaching peritoneal dialysis in Australia: An opportunity for improvement. Nephrology 2017.(DOI: 10.1111/nep.12992)

2. Campbell DJ, Mudge DW, Gallagher MP, Lim WH, Dwarakanathan R, Saweirs W, Craig JC. Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00037)

3. Kalil AC, Johnson DW, Lisco SJ, Sun J. Early goal-directed therapy for sepsis: A novel solution for discordant survival outcomes in clinical trials. Critical Care Medicine 2017. (DOI:   10.1097/ccm.0000000000002235)

4. Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC.  Beginning the trajectory to ESKD in adult life: Albuminuria in Australian aboriginal children and adolescents. Pediatric Nephrology 2017; 32(1), 119-129. (DOI: 10.1007/s00467-016-3429-y)

5. Lim WH, Wong G, Pilmore HL, McDonald SP,  Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: A population cohort study. Lancet Diabetes Endocrinology 2017; 5(1): 26-33. (DOI: 10.1016/s2213-8587(16)30317-5)

6. Mahady SE, Gale J, Macaskill P, Craig JC,  George J. Prevalence of elevated alanine transaminase in Australia and its relationship to metabolic risk factors: A cross-sectional study of 9,447 people. Journal of Gastroenterology and  Hepatology 2017; 32(1): 169-170. (DOI: 10.1111/jgh.13434)

7. Nataatmadja M, Cho Y, Johnson DW. Evidence for biocompatible peritoneal dialysis solutions. Contributions to Nephrology 2017; 189: 91-101. (DOI: 10.1159/000450690)

8. Pinter J, Hanson CS, Chapman JR, Wong G, Craig JC, Schell JO, Tong A. Perspectives of older kidney transplant recipients on kidney transplantation. Clinical Journal of the American Society of Nephrology 2017. (DOI: 10.2215/cjn.05890616)

9. Small DM, Beetham KS, Howden EJ, Briskey DR, Johnson DW, Isbel NM, Gobe GC, Coombes JS. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Reports 2017; 1-10. (DOI: 10.1080/13510002.2016.1276314

10. Sumpton D, Thakkar V, O’Neill S, Singh-Grewal D, Craig JC, Tong A. “It’s not me, it’s not really me.” Insights from patients on living with systemic sclerosis: An interview study. Arthritis Care Research 2017. (DOI: 10.1002/acr.23207)

11. Szeto CC, Johnson DW. Low GDP solution and glucose-sparing strategies for peritoneal dialysis. Seminars in Nephrology 2017; 37(1): 30-42. (DOI: 10.1016/j.semnephrol.2016.10.005)

12. Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, Crowe S, Van Biesen W, Winkelmayer WC, O’Donoghue D, Tam-Tham H, Shen JI, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC. Establishing core outcome domains in hemodialysis: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. American Journal of Kidney Diseases 2017; 69(1): 97-107. (DOI: 10.1053/j.ajkd.2016.05.022)

13. Tong A, Sautenet B, Chapman JR, Harper C, MacDonald SP, Shackel N, Crowe S, Hanson C, Hill S, Synnot A, Craig JC. Research priority setting in organ transplantation: A systematic review. Transplant International 2017; 30(4), 327-343. (DOI: 10.1111/tri.12924)

14. Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX. Patterns and predictors of screening for breast and cervical cancer in women with CKD. Clinical Journal of the American Society of Nephrology 2017; 12(1): 95-104. (DOI: 10.2215/cjn.05990616)

 

February 2017

1. Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology 2017; 21(1): 7-15.(DOI: 10.1007/s10157-016-1255-y)

2. Chan S, Au K, Francis RS, Mudge DW, Johnson DW, Pillans PI. Phosphate binders in patients with chronic kidney disease. Australian Prescriber 2017; 40(1): 10-14. (DOI: 10.18773/austprescr.2017.002)

3. Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M, Badve SV, Sud K, Hawley CM, Johnson DW. Association of socio-economic position with technique failure and mortality in Australian non-indigenous peritoneal dialysis patients. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00209)

4. Chan S, Mallett AJ, Patel C, Francis RS, Johnson DW, Mudge DW, Isbel NM. Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease. Nephrology 2017; 22 Suppl 1: 11-14. (DOI: 10.1111/nep.12933)

5. Chapman JR. Progress in transplantation: Will it be achieved in big steps or by marginal gains? American Journal of Kidney Disease 2017; 69(2): 287-295. (DOI: 10.1053/j.ajkd.2016.08.024)

6. Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O’Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC. Developing a set of core outcomes for trials in hemodialysis: An international delphi survey. American Journal of Kidney Diseases 2017. (DOI: 10.1053/j.ajkd.2016.11.029)

7. Fernando MR, Dent H, McDonald SP, Rangan GK. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in australia and new zealand (1963-2014). Popul Health Metr 2017; 15(1): 7. (DOI: 10.1186/s12963-017-0123-7)

8. Htay H, Johnson DW, Wu SY, Oei EL, Foo MW, Choo JC. Comparison of topical chlorhexidine and mupirocin for the prevention of exit-site infection in incident peritoneal dialysis patients. Peritoneal Dialysis International 2017. (DOI: 10.3747/pdi.2016.00257)

9. Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial. JAMA Intern Med 2017; 177(2): 184-193. (DOI: 10.1001/jamainternmed.2016.8029)

10. James LJ, Wong G, Craig JC, Ju A, Williams N, Lim WH, Cross N, Tong A. Beliefs and attitudes to bowel cancer screening in patients with CKD: A semistructured interview study. Clinical Journal of the American Society of Nephrology 2017; 12(4), 568-576. (DOI: 10.2215/cjn.10090916)

11. Kelly JT, Rossi M, Johnson DW, Campbell KL. Beyond sodium, phosphate and potassium: Potential dietary interventions in kidney disease. Seminars in Dialysis 2017. (DOI: 10.1111/sdi.12580)

12. Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC. Obesity and hypertension in australian young people: Results from the Australian health survey 2011-2012. Intern Med J 2017; 47(2): 162-169. (DOI: 10.1111/imj.13298)

13. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nature Reviews in Nephrol 2017; 13(2): 90-103. (DOI: 10.1038/nrneph.2016.181)

14. Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Mavridis D, Tonelli M, Johnson DW, Craig JC, Tong A, Strippoli GF. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: A network meta-analysis of randomized trials. American Jounral of Kidney Diseases 2017. (DOI: 10.1053/j.ajkd.2016.12.008)

15. Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bednarek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schon S, Wollheim C, Hegbrant J, Strippoli GF. Depression and all-cause and cardiovascular mortality in patients on haemodialysis: A multinational cohort study. Nephrology Dialysis Transplantation 2017; 32(2): 377-384. (DOI: 10.1093/ndt/gfw016)

16. Tong A, Winkelmayer WC, Wheeler DC, van Biesen W, Tugwell P, Manns B, Hemmelgarn B, Harris T, Crowe S, Ju A, O’Lone E, Evangelidis N, Craig JC. Nephrologists’ Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis.  Clinical Journal of the American Society of Nephrology 2017 (DOI: 10.2215/cjn.08370816)

17. Wong G, Chakera A, Chapman JR, Chadban SC, Pilmore H, Craig JC, Lim WH. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system? Transplantation and Infectious Diseases 2017; 19(1). (DOI: 10.1111/tid.12631)

 

March 2017

1. Campbell DJ, Mudge DW, Gallagher MP, Lim WH, Ranganathan D, Saweirs W, & Craig JC. Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey. Peritoneal Dialysis International 2017; 37(2), 191-197. (DOI: 10.3747/pdi.2016.00037)

2. Francis A, Johnson DW, Craig JC, & Wong G. Incidence and predictors of cancer following kidney transplantation in childhood. American Journal of  Transplantation 2017. (DOI: 10.1111/ajt.14289)

3. Mahady SE, Macaskill P, Craig JC, Wong GL, Chu WC, Chan HL, George J, Wong VW. Diagnostic accuracy of non-invasive fibrosis scores in a population of individuals with a low prevalence of fibrosis. Clinical Gastroenterology and Hepatology 2017. (DOI: 10.1016/j.cgh.2017.02.031)

4. Nankivell BJ, Renthawa J, Sharma RN, Kable K, O’Connell PJ, Chapman JR.  BK virus nephropathy: Histological evolution by sequential pathology. American Journal of Transplantation 2017. (DOI: 10.1111/ajt.14292)

5. Pinter J, Hanson CS, Chapman JR, Wong G, Craig JC, Schell JO, Tong A. Perspectives of older kidney transplant recipients on kidney transplantation. Clinical Journal of the American Society of Nephrology. 2017; 12(3), 443-453. (DOI: 10.2215/cjn.05890616)

6. Saglimbene V, Palmer SC, Craig JC, Ruospo M, Nicolucci A, Tonelli M, Johnson D, Lucisano G, Williams G, Valentini M, D’Alonzo D, Pellegrini F, Strippoli P, Salomone M, Santoro A, Maffei S, Hegbrant J, Tognoni G, Strippoli GF and CE-DOSE Study Investigators. Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial. PLoS One. 2017 Mar 1;12(3):e0172735. (DOI: 10.1371/journal.pone.0172735)

7. Small DM, Beetham KS, Howden EJ, Briskey DR, Johnson DW, Isbel NM, Gobe GC, Coombes JS. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report. 2017; 22(3): 127-136. (DOI: 10.1080/13510002.2016.1276314)

8. Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. ISPD catheter-related infection recommendations: 2017 update. Peritoneal Dialysis International 2017; 37(2): 141-154. (DOI: 10.3747/pdi.2016.00120)

9. Tong A, Winkelmayer WC, Wheeler DC, van Biesen W, Tugwell P, Manns B, Hemmelgarn B, Harris T, Crowe S, Ju A, O’Lone E, Evangelidis N, Craig JC.  Nephrologists’ perspectives on defining and applying patient-centered outcomes in hemodialysis. PLoS One 2017; 12(3): 454-466. (DOI: 10.1371/journal.pone.0172735 10.2215/cjn.08370816)

10.  Tunnicliffe DJ, Singh-Grewal D, Craig JC, Howell M, Tugwell P, Mackie F, Lin MW, O’Neill SG, Ralph AF, Tong A. Healthcare and research priorities of adolescents and young adults with systemic lupus erythematosus: A mixed-methods study. Journal of Rheumatology 2017  (DOI: 10.3899/jrheum.160720

11.  Wong G, Craig JC, Chapman JR. Setting the limit for living kidney donation-how big is too big? Kidney International 2017; 91(3): 534-536. (DOI: 10.2215/cjn.08370816 10.1016/j.kint.2016.11.027

12. Young C, Tong A, Gunasekera H, Sherriff S, Kalucy D, Fernando P, Craig JC.  Health professional and community perspectives on reducing barriers to accessing specialist health care in metropolitan Aboriginal communities: A semi-structured interview study. Journal of Paediatrics and Child Health. 2017; 53(3):277-282. (DOI: 10.1111/jpc.13374).

 

April 2017

1. Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GF. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database of Systematic Reviews2017; 4, Cd004679 (DOI: 10.1002/14651858.CD004679.pub32017)

2. Chong LSH, Sautenet B, Tong A, Hanson CS, Samuel S, Zappitelli M, Dart A, Furth S, Eddy AA, Groothoff J, Webb NJA, Yap HK, Bockenhauer D, Sinha A, Alexander SI, Goldstein SL, Gipson DS, Raman G, Craig JC. Range and heterogeneity of outcomes in randomized trials of pediatric chronic kidney disease. Journal of Pediatrics. 2017 (DOI: 10.1016/j.jpeds.2017.03.034)

3. Joseph PD, Caldwell PH, Barnes EH, Craig JC. Disease burden-research match? Registered trials in child health from low- and middle-income and high-income countries. Journal of Paediatrics and Child Health. 2017 (DOI: 10.1111/jpc.13537)

4. Kable K, Davies CD, O’Connell PJ, Chapman JR, Nankivell BJ. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Transplantion Direct. 2017; 3(4), e142. (DOI: 10.1097/txd.0000000000000641)

5. Nataatmadja M, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW. Association between peritoneal glucose exposure and peritonitis in peritoneal dialysis patients: The BALanz trial. Peritoneal Dialysis International. 2017.(DOI: 10.3747/pdi.2016.00263)

6. Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF. Dietary interventions for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017; 4, Cd011998. (DOI: 10.1002/14651858.CD011998.pub2)

7. Ritchie AG, Clayton PA, McDonald SP, Kennedy SE. Age-specific risk of renal graft loss from late acute rejection or noncompliance in the adolescent and young adult period. Nephrology 2017.(DOI: 10.1111/nep.13067)

8. Rossignol P, Agarwal R, Canaud B, Charney A, Chatellier G, Craig JC, Cushman WC, Gansevoort RT, Fellstrom B, Garza D, Guzman N, Holtkamp FA, London GM, Massy ZA, Mebazaa A, Mol PGM, Pfeffer MA, Rosenberg Y, Ruilope LM, Seltzer J, Shah AM, Shah S, Singh B, Stefansson BV, Stockbridge N, Stough WG, Thygesen K, Walsh M, Wanner C, Warnock DG, Wilcox CS, Wittes J, Pitt B, Thompson A, Zannad F. Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpoints. European Heart Journal. 2017 (DOI: 10.1093/eurheartj/ehx209)

 

May 2017

1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S,
Lunney M, Wiebe N, Ye F, Johnson DW. Assessment of Global Kidney Health Care Status. JAMA  2017;317(18):1864-81. (DOI 10.1186/s12882-017-0574-x)

2. Campbell KL, Palmer SC, Johnson DW. Improving Nutrition Research in Nephrology: An Appetite for Change. American Journal of Kidney Diseases. 2017;69(5):558-60.(DOI 10.1053/j.ajkd.2017.02.006.)

3. Manera KE, Hanson CS, Chapman JR, Kanellis J, Gill J, Craig JC, Chadban SJ, Wong G, Ralph AF, Tong A. Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study. Transplantation. 2017;101(10):2627-35.(DOI: 10.1097/TP.0000000000001771.)

4. Reith C, Staplin N, Herrington WG, Stevens W, Emberson J, Haynes R, Mafham M, Armitage J, Cass A, Craig JC, Jiang L, Pedersen T, Baigent C, Landray MJ, SHARP Collaborative Group. Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection. BMC nephrology. 2017;18(1):147.(DOI: 10.1186/s12882-017-0545-2.)

5. Ruospo M, Palmer SC, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Del Castillo D, Schon S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF. Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study. BMC nephrology. 2017;18(1):166.(DOI: 10.1186/s12882-017-0574-x).

6. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi L-S, Ong L-M, Irish AB, FAVOURED study team. Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology. 2017;22(10):823-4. (DOI: 10.1111/nep.12823.)

 

June 2017

1. Cho Y, Htay H, Johnson DW. Centre effects and peritoneal dialysis-related peritonitis. Nephrol Dial Transplant 2017; 32(6):913-915 (DOI 10.1093/ndt/gfx054)

 

July 2017

1. Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M,
Badve SV, Sud K, Hawley CM, Johnson DW. Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients. Peritoneal Dialysis International. 2017;37(4):397-406. (DOI 10.3747/pdi.2016.00209)

2. Francis A, Johnson DW, Craig JC, Wong G. Moving on: transitioning young people with chronic kidney disease to adult care. Pediatric Nephrology. 2017.(DOI: 10.1007/s00467-017-3728-y.)

3. Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P, HERO Study Collaborative Group. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology  2017;22(7):548-54.(DOI: 10.1111/nep.12815.)

4. Hoy WE, Mott SA, McDonald SP. Follow-up reply to Dr Paul Lawton’s “A response to an expanded nationwide view of chronic kidney disease in Aboriginal Australians, Nephrology, 21 (2016), 916-922”. Nephrology. 2017;22(7):574.(DOI: 10.1111/nep.13041.)

5. Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis. Clinical Journal of the American Society of Nephrology. 2017;12(7):1090-9.(DOI: 10.2215/CJN.12321216)

6. Webster AC, Wu S, Tallapragada K, Park MY, Chapman JR, Carr SJ. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. The Cochrane database of systematic reviews. 2017;7:Cd004756.(DOI: 10.1002/14651858.CD004756.pub4

 

August 2017

1. Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461-9. (DOI 10.1016/j.kint.2017.03.015).

2. Lawton PD, McDonald SP, Snelling PL, Hughes J, Cass A. Organ Transplantation in Australia: Inequities in Access and Outcome for Indigenous Australians. Transplantation. 2017. (DOI: 10.1097/TP.0000000000001911.)

3. Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu Z-H, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang H-Y, Perkovic V, TESTING Study Group. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA. 2017;318(5):432-42.(DOI: 10.1001/jama.2017.9362.)

4. Mohammadi FA, Borg M, Gulyani A, McDonald SP, Jesudason S. Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation. Clin Transplant. 2017.(DOI: 10.1111/ctr.13089.)

5. Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J,Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O’Donoghue D,Tam-Tham H, Halimi J-M, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC. Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation. 2017;101(8):1875-86.(DOI: 10.1097/TP.0000000000001776.)

6. Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM, Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, Dunning, T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wang AY, Wilkie M, Howell M, Sautenet B, Evangelidis N, Shen JI, Johnson DW. Standardized outcomes in nephrology-peritoneal dialysis (SONG-PD): Study protocol for establishing a core outcome set in PD. BMC Nephrology. (DOI 017.10.1186/s12882-017-0705-4, 10.3747/pdi.2017.00022).

 

Back to Top